HALISTER: Biogen CEO to Step Down, Authorizes $5b Buyback; 2Q EPS Beats

Biogen CEO to Step Down, Authorizes $5b Buyback; 2Q EPS Beats

(Bloomberg) -- Biogen 2Q adj. EPS $5.21 vs est. $4.69; boosts year forecast; shares rise 2.9% pre-market.
  • CEO George Scangos to step down
Statement: NSN OANVW0MEQTXK
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
BIIB US (Biogen Inc)

People
George Scangos (Biogen Inc)

Topics
Who's News - People
Management Changes

To de-activate this alert, click here

UUID: 7947283